Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections in the elderly and in children, associated with pediatric hospitalizations. Recently, first vaccines have been approved for people over 60 years of age applied by intramuscular injection. However, a vacc...

Descripció completa

Dades bibliogràfiques

Autors principals:	Valentina Eberlein, Mareike Ahrends, Lea Bayer, Julia Finkensieper, Joana Kira Besecke, Yaser Mansuroglu, Bastian Standfest, Franziska Lange, Simone Schopf, Martin Thoma, Jennifer Dressman, Christina Hesse, Sebastian Ulbert, Thomas Grunwald
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2023-08-01
Col·lecció:	Viruses
Matèries:	respiratory syncytial virus RSV mucosal vaccine inactivated vaccine low-energy electron irradiation LEEI
Accés en línia:	https://www.mdpi.com/1999-4915/15/9/1846
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!